RANI - Total Utang marang Modal Rani Therapeutics Holdings, Inc.

Logo perusahaan publik Rani Therapeutics Holdings (RANI)

Rani Therapeutics (RANI) is a pioneer in the field of oral delivery of biologics via the RaniPill system. The price indicator on the chart reflects a debt load of 0.09. The robo-pill technology replaces injections by delivering the drug directly into the intestinal epithelium. The business relies on automated facilities equipped with precision machinery, where the assembly of specialized capsules is conducted in sterile zones with stable capacity utilization.

RANI: Total Utang marang Modal Rani Therapeutics Inc 04.07.2022 - 31.10.2026

Rincian analitis perusahaan Rani Therapeutics

- rega lan prakiraan konsensus rega:
Bagan rega Rani Therapeutics Holdings|RANI - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Rani Therapeutics|RANI - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Rani Therapeutics|RANI - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku ranitherapeutics.com|RANI - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Rani Therapeutics|RANI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Rani Therapeutics Holdings|RANI - Gunggung utang perusahaan|Utang marang nilai buku Rani Therapeutics|RANI - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rani Therapeutics|Indikator likuiditas cepet ranitherapeutics.com
- informasi bathi lan kelipatan valuasi:
RANI - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Rani Therapeutics
Barang utama Rani Therapeutics Holdings, Inc.

Rani Therapeutics (RANI) is investing in the development of robotic capsules, where high engineering costs prior to FDA approval temporarily offset operational efficiency. The total liabilities-to-equity ratio quantifies this risk by measuring the proportion of debt financing within the balance sheet structure to assess solvency, which clearly reflects the trend of financial dependence via the debt-to-equity ratio.

Analisis pesaing Rani Therapeutics

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|Rasio Kabeh Utang marang Dana Pribadi ENTX|MindWalk - Total Utang marang Modal|ABVC - Total Utang marang Modal|Cumberland Pharmaceuticals (CPIX) - Utang marang Ekuitas|Rasio Utang marang Ekuitas QNTM|FGEN (FibroGen) - Total Utang marang Modal|Telomir Pharmaceuticals Inc (TELO) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas SNYR (Synergy CHC Corp)|RLYB (rallybio.com) - Rasio Kabeh Utang marang Dana Pribadi|Lexaria Bioscience Corp. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal PULM (pulmatrix.com)|Pheton - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi APM (Aptorum Group Limited)|LYRA: Total Utang marang Modal|Utang marang Modal Impact BioMedical, Inc. (IBO)|Utang marang Ekuitas TNF Pharmaceuticals Inc.|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|Total Utang marang Modal altamiratherapeutics.com (CYTO)|Utang marang Ekuitas Lipella LIPO|OPTN (OptiNose Corp) - Utang Agregat marang Ekuitas|Pieris Pharmaceuticals - Total Utang marang Modal|Utang marang Modal procapsgroup.com|PTPI (Petros Pharmaceuticals, Inc.) - Rasio Total Utang marang Ekuitas|Qilian International Holding Group (QLI) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas SLRN|TFFP (TFF Pharmaceuticals, Inc) - Utang Agregat marang Modal